MicroRNA-105 suppresses cell proliferation and inhibits PI3K/AKT signaling in human hepatocellular carcinoma

Carcinogenesis
Gang ShenHongyun Jia

Abstract

A growing amount of evidence supports that microRNA (miRNA) dysregulation is involved in cancer progression by directly downregulating multiple targets. Elucidating the underlying mechanism of miRNA in carcinogenesis may improve diagnostic and therapeutic strategies for malignancy. In the current study, we found that miR-105 expression was markedly downregulated in both hepatocellular carcinoma (HCC) cell lines and clinical HCC tissues, compared with normal human hepatocyte and adjacent non-cancerous tissues, respectively. Ectopic miR-105 expression suppressed, whereas inhibiting miR-105 promoted the proliferation and tumorigenicity of HCC cells both in vitro and in vivo. Furthermore, we demonstrated that miR-105 could deactivated the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway by downregulating insulin receptor substrate-1, 3-phosphoinositide-dependent protein kinase-1 and AKT1 directly, resulting in increasing cyclin-dependent kinase inhibitors 1A and 1B (p21(Cip1) and p27(Kip1)) and decreasing cyclin D1 expression in HCC. Therefore, our results suggest that miR-105 functions as a potential tumor suppressor by inhibiting the PI3K/AKT signaling pathway and might represent a potential therapeutic target for HCC patie...Continue Reading

References

Feb 28, 1992·Biochemical and Biophysical Research Communications·M Nishiyama, J R Wands
Apr 30, 1996·Annals of the New York Academy of Sciences·A BelfioreR Vigneri
Sep 18, 1996·Molecular and Cellular Endocrinology·P A WildenD E Broadway
Oct 23, 2001·International Journal of Cancer. Journal International Du Cancer·D M ParkinP Pisani
Mar 8, 2002·Cellular Signalling·Karleen M Nicholson, Neil G Anderson
Sep 17, 2004·Nature·Victor Ambros
Oct 28, 2004·Gastroenterology·F Xavier BoschRamon Cléries
Aug 13, 2005·Advances in Cancer Research·Alfonso BellacosaJoseph Robert Testa
Aug 16, 2005·The Journal of Clinical Investigation·Michael PotenteStefanie Dimmeler
Nov 17, 2005·Oncogene·Joseph R Testa, Philip N Tsichlis
Nov 17, 2005·Oncogene·Deborah A Altomare, Joseph R Testa
Oct 3, 2006·Developmental Cell·Wigard P Kloosterman, Ronald H A Plasterk
Dec 8, 2007·Journal of Cellular Physiology·Hongzhi Sun, Renato Baserga
Aug 22, 2008·Trends in Cell Biology·Tobias B Dansen, Boudewijn M T Burgering
Mar 11, 2010·Current Pharmaceutical Design·Amancio Carnero
Jan 6, 2011·The Journal of Pharmacology and Experimental Therapeutics·Kuen-Feng ChenAnn-Lii Cheng
Feb 8, 2011·CA: a Cancer Journal for Clinicians·Ahmedin JemalDavid Forman
Oct 14, 2011·Future Oncology·Qian ZhouWinnie Yeo
Dec 22, 2011·International Journal of Hepatology·Makoto MeguroKoichi Hirata
Sep 7, 2012·Neoplasia : an International Journal for Oncology Research·Paolo Armando GagliardiLuca Primo
Aug 21, 2013·PloS One·D Rice HoneywellChristina L Addison
Apr 17, 2014·Cancer Cell·Weiying ZhouShizhen Emily Wang

❮ Previous
Next ❯

Citations

Apr 19, 2015·Journal of Experimental & Clinical Cancer Research : CR·Germana FalconeIgea D'Agnano
Feb 11, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Mohammad Hojjat-Farsangi
Jan 23, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Gang CaoShiyuan Liu
Feb 20, 2015·Molecular Biology of the Cell·Wei CuiQiong Wu
May 12, 2015·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Hongyu Chi
Oct 14, 2016·FEBS Letters·Xiyao LiuShizhong Zhang
Jul 12, 2017·Reproduction in Domestic Animals = Zuchthygiene·G M AndradeJ C da Silveira
Jun 18, 2017·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jie ZhangXiaoming Lu
May 28, 2019·FEBS Letters·Shiruo WeiLi Shen
May 29, 2020·American Journal of Physiology. Gastrointestinal and Liver Physiology·Xiaohui WanRongfeng Qu
Jun 29, 2018·BioMed Research International·Erbao ChenTianshu Liu
Sep 27, 2019·Journal of Cellular Physiology·Shuang-Sang FangYi Zhao
Jul 10, 2019·Frontiers in Oncology·Jie LiYueming Sun
May 18, 2020·International Immunopharmacology·Gholamreza Rezaei DanbaranHamed Mohammadi
Feb 13, 2021·Annals of Human Genetics·Sohair Salem, Rehab Mosaad
Nov 19, 2020·Cancer Management and Research·Hong-Yu Zhang, Jian-Hui Ma
Nov 7, 2020·Cancer Management and Research·Yunpeng XieWeixing Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

AKT Pathway

This feed focuses on the AKT serine/threonine kinase, which is an important signaling pathway involved in processes such as glucose metabolism and cell survival.

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.